Systemic drugs that influence titanium implant osseointegration

References

• Abdelhamid AI. (2011). Scanning electron microscope evaluation of the effect of systemic administration of aspirin on the osseointegration of dental implants (experimental study). J Pak Dent Assoc 20:260–265.
   Google Scholar
• Abramson SB, Furst DE, Romain PL. (2016). Aspirin: mechanism of action, major toxicities, and use in rheumatic diseases [online]. UpToDate. In: Post TW, ed. Waltham, MA: UpToDate. Available from: http://www.uptodate.com/contents/aspirin-mechanism-of-action-major-toxicities-and-use-in-rheumatic-diseases [last accessed 4 Aug 2016].
   Google Scholar
• Agholme F, Isaksson H, Kuhstoss S, Aspenberg P. (2011). The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone 48:988–996.
   PubMed Web of Science ®Google Scholar
• Agholme F, Macias B, Hamang M, et al. (2014). Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing. J Orthop Res 32:471–476.
   PubMed Web of Science ®Google Scholar
• Albrektsson T, Brånemark PI, Hansson HA, et al. (1983). The interface zone of inorganic implants in vivo: titanium implants in bone. Ann Biomed Eng 11:27.
   Web of Science ®Google Scholar
• Alissa R, Sakk S, Oliver R, et al. (2009). Influence of ibuprofen on bone healing around dental implants: a randomised double-blind placebo controlled clinical study. Eur J Oral Implantol 2:185–199.
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Agholme F, Magnusson P, Fahlgren A. (2011). Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. Bone 48:225–230.
   PubMed Web of Science ®Google Scholar
• Ayukawa Y, Ogino Y, Moriyama Y, et al. (2010). Simvastatin enhances bone formation around titanium implants in rat tibiae. J Oral Rehabil 37:123–130.
   PubMed Web of Science ®Google Scholar
• Ayukawa Y, Okamura A, Koyano K. (2004). Simvastatin promotes osteogenesis around titanium implants. Clin Oral Implants Res 15:346–350.
   PubMed Web of Science ®Google Scholar
• Bernhardsson M, Sandberg O, Aspenberg P. (2015). Anti-RANKL treatment improves screw fixation in cancellous bone in rats. Injury 46:990–995.
   PubMed Web of Science ®Google Scholar
• Bikle DD. (2014). Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329.
   PubMed Web of Science ®Google Scholar
• Bobyn JD, Hacking SA, Krygier JJ, et al. (2005). Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br 87:416–420.
   PubMedGoogle Scholar
• Botting R, Ayoub SS. (2005). COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostagland Leukotrienes Essent Fatty Acids 72:85–87.
   PubMed Web of Science ®Google Scholar
• Botting RM. (2003). Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31:S202–S210.
   Web of Science ®Google Scholar
• Brouwers J, van Rietbergen B, Huiskes R, Ito K. (2009). Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT. Osteoporos Int 20:1823–1835.
   PubMed Web of Science ®Google Scholar
• Bryce G, Bomfim DI, Bassi GS. (2014). Pre- and post-operative management of dental implant placement. Part 1: Management of post-operative pain. Br Dent J 217:123–127.
   PubMed Web of Science ®Google Scholar
• Callahan BC, Lisecki EJ, Banks RE, et al. (1995). The effect of warfarin on the attachment of bone to hydroxyapatite-coated and uncoated porous implants. J Bone Joint Surg Am 77:225–230.
   PubMed Web of Science ®Google Scholar
• Cannata-Andia JB, Rodriguez-Garcia M, Gómez-Alonso C. (2010). Action mechanism of strontium ranelate. Rev Osteoporos Metab Miner 2:S5–S9.
   Google Scholar
• Cardeemil C, Omar OM, Norlindh B, et al. (2013). The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model. Biomaterials 34:1546–1561.
   PubMed Web of Science ®Google Scholar
• Chacon GE, Stine EA, Larsen PE, et al. (2006). Effect of alendronate on endosseous implant integration: an in vivo study in rabbits. J Oral Maxillofac Surg 64:1005–1009.
   PubMed Web of Science ®Google Scholar
• Chen B, Li Y, Yang X, et al. (2013). Zoledronic acid enhances bone–implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Osteoporos Int 24:2115–2121.
   PubMed Web of Science ®Google Scholar
• Chen BL, Xie DH, Zheng ZM, et al. (2011). Comparison of the effects of alendronate sodium and calcitonin on bone-prosthesis osseointegration in osteoporotic rats. Osteoporos Int 22:265–270.
   PubMed Web of Science ®Google Scholar
• Chikazu D, Tomizuka K, Ogasawara T, et al. (2007). Cyclooxygenase-2 activity is essential for the osseointegration of dental implants. Int J Oral Maxillofac Surg 36:441–446.
   PubMed Web of Science ®Google Scholar
• Coetzee M, Kruger MC. (2004). Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment? South Med J 97:506–511.
   PubMed Web of Science ®Google Scholar
• Cook SD, Barrack RL, Dalton JE, et al. (1995). Effects of indomethacin on biologic fixation of porous-coated titanium implants. J Arthroplasty 10:351–358.
   PubMed Web of Science ®Google Scholar
• Dayer R, Badoud I, Rizzoli R, Ammann P. (2007). Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. J Bone Miner Res 22:1526–1533.
   PubMed Web of Science ®Google Scholar
• Dayer R, Brennan TC, Rizzoli R, Ammann P. (2010). PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet. Osteoporos Int 21:957–967.
   PubMed Web of Science ®Google Scholar
• Du Z, Chen J, Yan F, Xiao Y. (2009). Effects of simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Implants Res 20:145–150.
   PubMed Web of Science ®Google Scholar
• Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, et al. (2005). Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol 76:107–114.
   PubMed Web of Science ®Google Scholar
• Eberhardt C, Schwarz M, Kurth AH. (2005). High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants. J Orthop Sci 10:622–626.
   PubMed Web of Science ®Google Scholar
• Eberhardt C, Stumpf U, Brankamp J, et al. (2006). Osseointegration of cementless implants with different bisphosphonate regimens. Clin Orthop Relat Res 447:195–200.
   PubMed Web of Science ®Google Scholar
• Eriksen EF. (2006). Effects of anticatabolic and anabolic therapies oat the tissue level. Clin Rev Bone Miner Metabol 4:177–196.
   Google Scholar
• Fonseca JE, Brandi ML. (2010). Mechanism of action of strontium ranelate: what are the facts? Clin Cases Miner Bone Metab 7:17–18.
   PubMedGoogle Scholar
• Fu JH, Bashutski JD, Al-Hezaimi K, Wang HL. (2012). Statins, glucocorticoids, and nonsteroidal anti-inflammatory drugs: their influence on implant healing. Implant Dent 21:362–367.
   PubMed Web of Science ®Google Scholar
• Galea GL, Price JS, Lanyon LE. (2013). Estrogen receptors' roles in the control of mechanically adaptive bone (re)modeling. Bonekey Rep 2:413.
   PubMedGoogle Scholar
• Gasparyan A, Watson T, Lip GH. (2008). The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 51:1829–1843.
   PubMed Web of Science ®Google Scholar
• Giro G, Gonçalves D, Sakakura CE, et al. (2008). Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: a radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:162–167.
   PubMed Web of Science ®Google Scholar
• Gomes FIF, Aragäo MGB, Pinto V, de PT, et al. (2015). Effects of nonsteroidal anti-inflammatory drugs on osseointegration: a review. J Oral Implantol 41:219–230.
   PubMed Web of Science ®Google Scholar
• Gong L, Altman RB, Klein TE. (2011). Bisphosphonates pathway. Pharmacogenet Genom 21:50–53.
   PubMed Web of Science ®Google Scholar
• Graham S, Gamie Z, Polyzois I, et al. (2009). Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence. Expert Opin Investig Drugs 18:746–766.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Fotovati A, Abu Ali S, et al. (2010). Effect of a prostaglandin EP4 receptor agonist on early fixation of hydroxyapatite/titanium composite- and titanium-coated rough-surfaced implants in ovariectomized rats. J Biomed Mater Res A 92:1202–1209.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Fotovati A, Ali SA, et al. (2005). Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis. J Bone Joint Surg Br 87:1150–1156.
   PubMedGoogle Scholar
• Jacobsson SA, Djerf K, Ivarsson I, Wahlström O. (1994). Effect of diclofenac on fixation of hydroxyapatite-coated implants. An experimental study. J Bone Joint Surg Br 76:831–833.
   PubMedGoogle Scholar
• Javed F, Al Amri MD, Kellesarian SV, et al. (2016a). Efficacy of parathyroid hormone supplementation on the osseointegration of implants: a systematic review. Clin Oral Investig 20:649–658.
   PubMed Web of Science ®Google Scholar
• Javed F, Malmstrom H, Kellesarian SV, et al. (2016b). Efficacy of vitamin D3 supplementation on osseointegration of implants. Implant Dent 25:281–287.
   PubMed Web of Science ®Google Scholar
• Jeffcoat MK, Reddy MS, Wang IC, et al. (1995). The effect of systemic flurbiprofen on bone supporting dental implants. J Am Dent Assoc 126:305–311.
   PubMed Web of Science ®Google Scholar
• Jensen TB, Bechtold JE, Chen X, Søballe K. (2007). Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants. J Orthop Res 25:772–778.
   PubMed Web of Science ®Google Scholar
• Kurth AH, Eberhardt C, Müller S, et al. (2005). The biphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone 37:204–210.
   PubMed Web of Science ®Google Scholar
• Lau HK, Mounsey A, Mackler L. (2012). Human parathyroid hormone for treating osteoporosis. Am Fam Phys. 85:1–2.
   Google Scholar
• Li M, Wang W, Geng L, et al. (2015). Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis. Int J Mol Med 36:1335–1344.
   PubMed Web of Science ®Google Scholar
• Li Y, Feng G, Gao Y, et al. (2010). Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 28:578–582.
   PubMed Web of Science ®Google Scholar
• Linderback P, Agholme F, Wermelin K, et al. (2012). Weak effect of strontium on early implant fixation in rat tibia. Bone 50:350–356.
   PubMed Web of Science ®Google Scholar
• Lionberger DR, Noble PC. (2005). Celecoxib does not affect osteointegration of cementless total hip stems. J Arthroplasty 20:115–122.
   PubMed Web of Science ®Google Scholar
• Liu AS, Irish J, Sena K, et al. (2015). Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis. J Bone Joint Surg Am 97:133–140.
   PubMed Web of Science ®Google Scholar
• Long M, Rack HJ. (1998). Titanium alloys in total joint replacement—a materials science perspective. Biomaterials 19:1621–1639.
   PubMed Web of Science ®Google Scholar
• Lütjering G, Williams JC. (2007). Titanium. 2nd ed. Berlin Heidelberg: Springer-Verlag.
   Google Scholar
• Mangravite LM, Thorn CF, Krauss RM. (2012). Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414–417.
   PubMed Web of Science ®Google Scholar
• Mardas N, Schwarz F, Petrie A, et al. (2011). The effect of SLActive surface in guided bone formation in osteoporotic-like conditions. Clin Oral Implants Res 22:406–415.
   PubMed Web of Science ®Google Scholar
• Masi L, Brandi ML. (2007). Calcitonin and calcitonin receptors. Clin Cases Miner Bone Metab 4:117–122.
   PubMedGoogle Scholar
• Matziolis G, Perka C, Disch A, Zippel H. (2003). Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts. Calcif Tissue Int 73:370–379.
   PubMed Web of Science ®Google Scholar
• Mavrogenis AF, Dimitriou R, Parvizi J, Babis GC. (2009). Biology of implant osseointegration. J Musculoskelet Neuronal Interact 9:61–71.
   PubMed Web of Science ®Google Scholar
• Murai K, Takeshita F, Ayukawa Y, et al. (1996). Light and electron microscopic studies of bone—titanium interface in the tibiae of young and mature rats. J Biomed Mater Res 30:523–533.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Hayashi K, Abu-Ali S, et al. (2008). Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats. J Bone Joint Surg Am 90:824–832.
   PubMed Web of Science ®Google Scholar
• Narai S, Nagahata S. (2003). Effects of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants 18:218–223.
   PubMed Web of Science ®Google Scholar
• Nellie AKW. (2008). Regulation of sclerostin expression in osteocytes by mechanical loading. Thesis (PhD). University of Missouri-Kansas City.
   Google Scholar
• Nociti FHJ, Sallum AW, Sallum AS, Duarte PM. (2002). Effect of estrogen replacement and calcitonin therapies on bone around titanium implants placed in ovariectomized rats: a histometric study. Int J Oral Maxillofac Implants 17:786–792.
   PubMed Web of Science ®Google Scholar
• Nociti FHJ, Sallum EA, Toledo S, et al. (1999). Effect of calcitonin on bone healing following titanium implant insertion. J Oral Sci 41:77–80.
   PubMedGoogle Scholar
• Olivares-Navarrete R, Hyzy S, Wieland M, et al. (2010). The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces. Biomaterials 31:2015–2024.
   PubMed Web of Science ®Google Scholar
• Oshida Y. (2013). Bioscience and bioengineering of titanium materials. Amsterdam: Elsevier.
   Google Scholar
• Pablos AB, Ramalho SA, König B, Jr, et al. (2008). Effect of meloxicam and diclofenac sodium on peri-implant bone healing in rats. J Periodontol 79:300–306.
   PubMed Web of Science ®Google Scholar
• Peters M, Hemptenmacher J, Kumpfert J, Leyens C. (2003). Structure and properties of titanium and titanium alloys: fundamentals and applications. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA.
   Google Scholar
• Pinzone JJ, Hall BM, Thudi NK, et al. (2009). The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood J 113:517–525.
   PubMed Web of Science ®Google Scholar
• Puleo DA, Nanci A. (1999). Understanding and controlling the bone–implant interface. Biomaterials 20:2311–2321.
   PubMed Web of Science ®Google Scholar
• Purroy J, Spurr NK. (2002). Molecular genetics of calcium sensing bone cells. Hum Mol Genet 20:2377–2384.
   Web of Science ®Google Scholar
• Qi H, Hu J, Li J, et al. (2012). Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone 50:119–127.
   PubMed Web of Science ®Google Scholar
• Ramalho-Ferreira G, Faverani LP, Prado FB, et al. (2015). Raloxifene enhances peri-implant bone healing in osteoporotic rats. Int J Oral Maxillofac Surg 44:798–805.
   PubMed Web of Science ®Google Scholar
• Reddy MS, Jeffcoat MK, Richardson RC. (1990). Assessment of adjunctive flurbiprofen therapy in root-form implant healing with digital subtraction radiography. J Oral Implantol 16:272–276.
   PubMedGoogle Scholar
• Rey JRC, Cervino EV, Rentero ML, et al. (2009). Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice. Open Orthop J 3:14–21.
   PubMedGoogle Scholar
• Ribeiro FV, César-Neto JB, Nociti FH, Jr, et al. (2006). Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats. J Periodontol 77:1731–1735.
   PubMed Web of Science ®Google Scholar
• Rosen HN. (2016). Pharmacology of biphosphonates [online]. UpToDate. In: Post TW, ed. Waltham, MA: UpToDate. Available from: http://www.uptodate.com/contents/pharmacology-of-bisphosphonates [last accessed 29 May 2016].
   Google Scholar
• Ruan F, Zheng Q, Wang J. (2012). Mechanisms of bone anabolism regulated by statins. Biosci Rep 32:511–519.
   PubMed Web of Science ®Google Scholar
• Russell RGG, Watts NB, Ebetino FH, Rogers MJ. (2008). Mechanisms of action of biphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733–759.
   PubMed Web of Science ®Google Scholar
• Saari TM, Digas G, Kärrholm JN. (2014). Risedronate does not enhance fixation or BMD in revision cups: randomised study with three years follow-up. Hip Int 24:49–55.
   PubMed Web of Science ®Google Scholar
• Serada M, Sakurai-Tanikawa A, Igarashi M, et al. (2012). The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats. Xenobiotica 42:398–407.
   PubMed Web of Science ®Google Scholar
• Shin JM, Kim N. (2013). Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil 19:25–35.
   PubMed Web of Science ®Google Scholar
• Skoglund B, Holmertz J, Aspenberg P. (2004). Systemic and local ibandronate enhance screw fixation. J Orthop Res 22:1108–1113.
   PubMed Web of Science ®Google Scholar
• Sköldenberg O, Rysinska A, Eisler T, et al. (2016). Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial. BMC Musculoskelet Disord 17:174.
   PubMed Web of Science ®Google Scholar
• Sköldenberg OG, Salemy MO, Bodėn HS, et al. (2011). The effect of weekly risendronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 93:1857–1864.
   PubMed Web of Science ®Google Scholar
• Skripitz R, Aspenberg P. (2001). Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg Br 83:437–440.
   PubMed Web of Science ®Google Scholar
• Stepan JJ. 2013. Strontium ranelate: in search for the mechanism of action. J Bone Miner Metab 31:606–612.
   PubMed Web of Science ®Google Scholar
• Stevenson JC. 1990. New techniques in metabolic bone disease. London: Butterworth & Co.
   Google Scholar
• Stroup J, Kane M, Abu-Baker A. (2008). Teriparatide in the treatment of osteoporosis. Am J Health Syst Pharm 65:532–539.
   PubMed Web of Science ®Google Scholar
• Subaie AA, Emami E, Tamimi I, et al. (2016). Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae. J Clin Periodontol 43:193–203.
   PubMed Web of Science ®Google Scholar
• Tallarico M, Canullo L, Xhanari E, Meloni SM. (2015). Dental implants treatments outcomes in patient under active therapy with alendronate: a 3-year follow-up results of a multicentric prospective observational study. Clin Oral Implants Res 27:943–949.
   PubMed Web of Science ®Google Scholar
• Tang XL, Meng HX, Zhang L. (2008). Effects of calcitriol on the expression of vitamin D receptor, RANKL and osteoprotegerin in human periodontal ligament cells. Zhonghua Kou Qiang Yi Xue Za Zhi 43:732–736.
   PubMedGoogle Scholar
• Tao ZS, Zhou WS, Tu KK, et al. (2015). The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on osseous integration of hydroxyapatite coated titanium implants in the femur of ovariectomized rats. Injury 45:2164–2169.
   Web of Science ®Google Scholar
• The glossary of prosthodontic terms. (2005). J Prosthet Dent 94:10–92.
   PubMed Web of Science ®Google Scholar
• Thomsen P, Larsson C, Ericson LE, et al. (1997). Structure of the interface between rabbit cortical bone and implants of gold, zirconium and titanium. J Mater Sci Mater Med 8:653–665.
   PubMed Web of Science ®Google Scholar
• Tong X, Lu W, You T, et al. (2016). The function of narginin in inducing secretion of osteoprotegerin and inhibiting formation of osteoclasts. Evid Based Complement Altern Med. 2016:8981650.
   PubMed Web of Science ®Google Scholar
• Trancik T, Mills W, Vinson N. (1989). The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthopaed Relat Res 249:113–121.
   PubMed Web of Science ®Google Scholar
• Turku University Hospital. (2013). Denosumab in enhancement of bone bonding of hip prosthesis in postmenopausal women (ProliaHip) [online]. Bethesda (MD): National Library of Medicine. Available from: https://clinicaltrials.gov/ct2/show/NCT01926158 [last accessed 28 Jul 2016].
   Google Scholar
• Viera-Negron YE, Ruan WH, Winger JN, et al. (2008). Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol 34:76–82.
   PubMedGoogle Scholar
• Virdi AS, Liu M, Sena K, et al. (2012). Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. J Bone Joint Surg Am 94:1670–1680.
   PubMed Web of Science ®Google Scholar
• von Knoch M, Wedemeyer C, Pingsmann A, et al. (2005). The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 36:1803–1808.
   Web of Science ®Google Scholar
• Weir EC, Horowitz MC, Baron R, et al. (1993). Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8:1507–1518.
   PubMed Web of Science ®Google Scholar
• Wolozin B, Wang SW, Li NC, et al. (2007). Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 5:20.
   PubMed Web of Science ®Google Scholar
• Wu X, Al-Abedalla K, Rastikerdar E, et al. (2014). Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study. J Dent Res 93:1054–1061.
   PubMed Web of Science ®Google Scholar
• Wurnig C, Schwameis E, Bitzan P, Kainberger F. (1993). Six-year results of a cementless stem with prophylaxis against heterotopic bone. Clin Orthopaed Relat Res 361:150–158.
   Google Scholar
• Yamashita M, Otsuka F, Mukai T, et al. (2010). Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept 162:99–108.
   PubMedGoogle Scholar
• Yang Y, Blair HC, Shapiro IM, Wang B. (2015). The proteasome inhibitor carfilzomib suppresses parathyroid hormone-induced osteoclastogenesis through a RANKL-mediated signaling pathway. J Biol Chem 290:16918–16928.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Esen E, Kürkçü M, et al. (2010). Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model. J Oral Maxillofac Surg 68:515–523.
   PubMed Web of Science ®Google Scholar
• Zhou C, Li Y, Wang X, et al. (2012). 1,25-Dihydroxy vitamin D3 improves titanium implant osseointegration in osteoporotic rats. Oral Surg Med Oral Pathol Oral Radiol 114:174–178.
   Web of Science ®Google Scholar